Proteomics International raises $6m in heavily oversubscribed Placement

Funds from the Placement will be used for:

• Manufacture & up-scaling of reagent inventory for the PromarkerD predictive test
• Marketing of, and accelerating regulatory approvals for PromarkerD
• Accelerating the development and commercialisation of the Company’s Promarker™ pipeline
• Strengthening the Company’s balance sheet for future licensing negotiations
• General working capital

Media Release